Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatocyte Growth Factor Gene Therapy for Ischemic Diseases

7 Feb 2018

Abstract excerpt

Stem cells and gene therapy have become promising strategies for treating ischemic diseases and regenerating tissue. Hepatocyte growth factor (HGF) is an angiogenic growth factor with multiple functions, including promoting angiogenesis, regulating inflammation, inhibiting fibrosis, and activating tissue regeneration. Numerous preclinical experiments and clinical trials have demonstrated the feasibility and...

Topics

Join the communities discussing this publication.

Liver physiology and pathology
Mesenchymal stem cell research
Organ Transplantation Techniques and Outcomes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29409352
DOI: 10.1089/hum.2017.217

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatocyte Growth Factor Gene Therapy for Ischemic DiseasesPMID 29409352Read ↗

Therapeutic Angiogenesis using Hepatocyte Growth Factor (HGF)Semantic proximity Read ↗

Advancements in Gene-Based Therapeutic Angiogenesis for Chronic Limb-Threatening IschemiaSemantic proximity Read ↗

Gene Therapy with Hepatocyte Growth Factor Improves Left Ventricular Systolic Function After Myocardial Infarction: A Systematic Review and Meta-analysis of Pig ModelsSemantic proximity Read ↗

Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes MellitusSemantic proximity Read ↗

Human Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hind Limb Ischemia by Promoting Angiogenesis in MiceSemantic proximity Read ↗

The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesisSemantic proximity Read ↗

pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcers: A Phase II, Double-Blind, Randomized Placebo-Controlled TrialSemantic proximity Read ↗

Preclinical Evaluation of Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb IschemiaSemantic proximity Read ↗

Gene therapy for peripheral arterial diseaseSemantic proximity Read ↗

Gene of the month: <i>HGF</i>Semantic proximity Read ↗

Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarctionSemantic proximity Read ↗

Vascular regeneration and skeletal muscle repair induced by long-term exposure to SDF-1α derived from engineered mesenchymal stem cells after hindlimb ischemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.